1. Home
  2. PBLS vs ATAT Comparison

PBLS vs ATAT Comparison

Compare PBLS & ATAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$32.74

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Logo Atour Lifestyle Holdings Limited

ATAT

Atour Lifestyle Holdings Limited

HOLD

Current Price

$32.82

Market Cap

4.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBLS
ATAT
Founded
N/A
2013
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
4.3B
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
PBLS
ATAT
Price
$32.74
$32.82
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $49.00
AVG Volume (30 Days)
★ 704.8K
661.2K
Earning Date
N/A
05-13-2026
Dividend Yield
N/A
★ 2.06%
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$25.48
Revenue Next Year
N/A
$18.11
P/E Ratio
★ N/A
$26.11
Revenue Growth
N/A
N/A
52 Week Low
$25.56
$30.78
52 Week High
$42.49
$43.17

Technical Indicators

Market Signals
Indicator
PBLS
ATAT
Relative Strength Index (RSI) 39.32 47.38
Support Level $26.42 $31.00
Resistance Level $33.65 $33.38
Average True Range (ATR) 3.14 0.85
MACD -0.93 0.01
Stochastic Oscillator 21.56 70.56

Price Performance

Historical Comparison
PBLS
ATAT

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

About ATAT Atour Lifestyle Holdings Limited

Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.

Share on Social Networks: